Medindia

X

CHRI Signs Cooperation Contract with Guangzhou Qingping Trade Center; Sees Further Progress in the Herbal Medicine Markets Across Southern China and Southeast Asia

Tuesday, October 23, 2007 General News J E 4
Advertisement
SUINING, China, Oct. 22 China Health Resource, Inc.(OTC Bulletin Board: CHRI) announced today that it has signed a cooperationcontract with Guangzhou Qingping Trade Center (''Qingping''), one of the fourbiggest herbal medicine and healthcare products markets in China. CHRI will,according to the contract, establish a South China Sales and Logistics Centerfor Suining Chuan Dahurian Angelica Root (DAR) and related products inQingping, meanwhile, Qingping will greatly boost the sales of Chuan DAR andrelated products in the area with its great influence in Southeast Asia'sherbal medicine markets.

The CHRI South China Sales and Logistics Center is located at the Phase IItransaction section of Guangzhou Qingping Trade Center with a 300 square meterfirst-class office, a 220 square meter exhibition center, and an 1800 squaremeter international-standard warehousing center. It's a signal of thebeginning of the market expansion in South China and Southeast Asia. TheSouth China Sales and Logistics Center is predicted to generate revenue of$2.5 million annually.

Guangzhou Qingping Trade Center has a history of 20 years. It is thebiggest trading market and distribution center, as well as the biggest import-export trading port of medicine and healthy food materials. According to theofficial data, the gross trading revenue of the market in 2006 was $0.4billion. The daily customer flow is 100,000 people. It is expected thattrading revenues will hit $0.66 billion in 2008.

About the Company

China Health Resource, Inc. (CHRI) was incorporated on April 24, 2001. Itis one of China's leading industrialized agricultural corporations. CHRIfocuses on the production and further processing of Dahurian Angelica Root(DAR), a herb that is widely used and considered to be an important ingredientin Chinese traditional medicines. CHRI's business plan includes distributingDAR and the processed products to exploit a large market in the areas oftreatment of pain, swelling and pustule. Good Agricultural Practice (GAP) isa national compulsory criterion for food and drug industries. The goal of GAPis to help agricultural product companies deal with the usual micro-organismharm so as to strengthen agricultural product safety. CHRI has accomplishedthe GAP certification of Chuan DAR, making the DAR products and relatedproduction technology of the Company become the industry criteria.

Statements regarding financial matters in this press release other thanhistorical facts are 'forward-looking statements' within the meaning ofsection 27A of the Securities Act of 1933, Section 21E of the SecuritiesExchange Act of 1934, and as that term is defined in the Private SecuritiesLitigation Reform Act of 1995. The Company intends that such proclamationsabout future expectations, including future revenues and earnings and allother forward-looking statements be subject to the safe harbors createdthereby. CHRI depends on outside resources to maintain its continuation.Since these statements involve risks and uncertainties and are subject tochange at any time, the Company's actual results may differ materially fromexpected results.For more information, please contact: China Health Resource, Inc. Tel: +86-825-2391788 343 Suining Zhong Road, Suining, Sichuan, P.R. China Web: http://www.chinahealthresources.com

SOURCE China Health Resource, Inc.
Advertisement


Advertisement

You May Also Like

Advertisement
View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
s
Good Healthcare Just Got Easier to Find
S
Sinovac Enters Purchase Agreement with Beijing Pub...